You are here

home  ›  site search

Search

Researchers

Upcoming events

Research Areas

Addiction
ADDICTION
> Read More
Immunology
AUTOIMMUNE AND AUTOINFLAMMATORY DISEASES
> Read More
Trauma
BLAST TRAUMA
> Read More
Cancer
BLOOD CANCER
> Read More
Immunology
BONE AND JOINT DISEASES
Researchers at TRI are investigating bone and joint diseases including rheumatoid arthritis,...
> Read More

Gene could guide better treatment of most common breast cancer

Article
Gene could guide better treatment of most common breast cancer Scientists have identified a gene which if present in certain breast cancer patients indicates how they will respond to specific...Read more

Genetic test could improve osteoporosis screening

Article
Genetic testing could improve screening for osteoporosis An international team of scientists has developed a novel genetic measure that could dramatically improve how doctors assess the risk of...Read more

Researchers optimising cancer survivors’ outcomes

Article
Researchers optimising cancer survivors’ outcomes Brisbane cancer nurse scientists are working alongside clinicians and scientists to develop better healthcare models for cancer survivors. QUT...Read more

WORLD-FIRST GENETIC & ENVIRONMENTAL RISKS IDENTIFIED FOR CHILDHOOD EPILEPSY

Article
World first genetic and environmental risks identified for common form of childhood epilepsy A new study of childhood epilepsy has identified maternal smoking in pregnancy as an important risk factor...Read more

Diabetes drug could prevent kidney failure

Article
Diabetes drug could prevent kidney failure An affordable diabetes drug could save generations of Australian families who live with polycystic kidney disease from kidney failure. MRFF funding for...Read more

Another World First Surgery for ACCISS

Article
The ACCISS team have completed another world first surgery using 3D printed technology to improve a birth defect known as “funnel chest.” The surgery was a collaboration between ACCISS...Read more

CSL signs deal for new autoimmune disease therapeutic

Article
CSL signs deal for new autoimmune disease therapeutic Biotech leader, CSL has announced a partnership deal to develop and commercialise an autoimmune disease therapeutic developed by The University...Read more

Tackling Type 1 diabetes from prevention to better treatments

Article
Tackling Type 1 diabetes from prevention to better treatments At the Translational Research Institute, a Mater Research group led by Professor Josephine Forbes is at the international forefront of...Read more

Improving genetic testing for skin cancer

Article
Improving genetic testing for skin cancer Genetic researcher and counsellor, Dr Aideen McInerney-Leo is leading a series of multifaceted studies aimed at improving genetic testing for skin cancer ...Read more

Early breakthrough with cancer vaccine

Article
TRI-based Mater researchers in partnership with The University of Queensland have developed a new cancer vaccine, which has shown promising signs in preclinical laboratory studies. Funded by grants...Read more

New endometrial cancer diagnostic

Article
New Biomarker for Poor Prognosis Endometrial Cancer A newly discovered endometrial cancer biomarker and diagnostic method will enable detection of the tumour type that is likely to spread and recur...Read more

Internships focusing Year 12's STEM Ambitions

Article
QUT Internships at TRI help Year 12s Focus STEM Ambitions The rigorous program develops students' technical, leadership and critical thinking skills through a suite of on-campus practical...Read more

Drug used to slow kidney disease ineffective

Article
A new study by Australian and New Zealand researchers will inform international clinical treatment guidelines for chronic kidney disease, after the team found a drug used to slow the disease in up to...Read more

Quest for personalised lung-cancer treatment

Article
Quest for Personalised Treatments to Improve Lung-Cancer Patient Outcomes Cure Cancer, with support from the Denton Trust, have awarded a grant to TRI based Dr Mark Adams. Mark will be expanding on...Read more

Mater Research Leads Queensland-first Trial Assessing Impacts of COVID-19 on Expectant Parents

Article
Mater Research Leads Queensland-first Trial Assessing Impacts of COVID-19 on Expectant Parents Led by Mater Research’s Professor Vicki Clifton, based at TRI, the landmark study will assess the...Read more

Lifetime dedicated to prostate and bladder cancer research

Article
A lifetime dedicated to prostate and bladder cancer research A new, targeted antibody-based treatment and diagnostic for prostate and bladder cancers is one of several important outcomes from the...Read more

Tissue engineering advancing medical care

Article
Research at TRI is helping advance regenerative medicine, tissue engineering and cell therapies to overcome the health burden associated with ageing populations and increasing chronic disease...Read more

New evidence of dangers of high-fat diet on pre-cancerous condition

Article
Brisbane scientists have found that eating a high-fat diet over a long period-of-time may induce early Barrett’s oesophagus, a precursor condition to oesophageal cancer. TRI awarded a 2015...Read more

Partnerships propel new vaccine delivery platform

Article
Australian biotech company, Vaxxas, has announced two important new partnerships in its bid to revolutionise vaccine delivery. TRI-based Vaxxas, which is commercialising a needle-free vaccine...Read more

New ovarian cancer diagnostic going to trial

Article
TRI researchers have received vital funding from the Australian Government to trial a new diagnostic for epithelial ovarian cancer (EOC), the first study of its kind in humans. Mater Research...Read more

Grant a boost for bone metastasis research

Article
A new research grant will help researchers better understand and potentially treat prostate cancer, which has spread to the bones. Cure Cancer Australian, Cancer Australia and the Can Too Foundation...Read more

Using placenta stem cells to help bones mend

Article
USing placenta stem cells to help bones mend Scientists based at TRI are developing a new regenerative medicine treatment to help mend fractured bones using stem cells taken from placentas. Associate...Read more

Unpacking the role of messenger proteins in diseases

Article
An arsenal of proteins used by many cell types to communicate with and control other cells could hold the answers to treating a multitude of diseases, especially cancer. The University of Queensland...Read more

Genomics research to improve Indigenous health

Article
QUT and UQ researchers based at TRI are part of team looking to improve health outcomes among Aboriginal and Torres Strait Islander communities by better understanding genetic association with...Read more

Making translational research easier in QLD

Article
Making the Business of Translational Research Easier in QLD The BDHP Research Passport Agreement has been updated and aims to streamline the approval process for researchers, saving them time and...Read more

Latest TRI grants boost cancer research

Article
TRI has awarded three new research grants worth $831,745 to fast-track innovative research aimed at improving outcomes for cancer patients . The grants, which include co-funding from university,...Read more

World-first saliva test detects hidden throat cancer

Article
QUT biomedical scientists affiliated with TRI have developed a simple saliva test, which has detected early throat cancer in a person who had no symptoms and no clinical signs of cancer. In what is...Read more

Directors’ Choice Series Launches at TRI

Article
DIRECTORS’ CHOICE SERIES LAUNCHES AT TRI Would you like to know what an editor looks for when picking journals? This session will provide you with insights from current and past editors and...Read more

Growth hormone boosts liver surgery success

Article
Growth hormone plays a key role in reducing inflammation and increasing survival rates following liver surgery. TRI-based researchers at The University of Queensland Diamantina Institute investigated...Read more

New ovarian and pancreatic cancer treatment

Article
Australian scientists are ready to trial a new ‘precision-medicine’ agent designed to deliver imaging agents and anti-cancer drugs to ovarian and pancreatic cancers in patients with...Read more

Pages